Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Dagi Shahar Ben-Noon Purchases 14,093 Shares of Company Stock

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Ben-Noon purchased 14,093 shares of Inspira Technologies OXY B.H.N. stock in a transaction that occurred on Tuesday, October 13th. The shares were bought at an average cost of $1.49 per share, for a total transaction of $20,998.57. Following the completion of the transaction, the chief executive officer directly owned 14,093 shares in the company, valued at $20,998.57. This represents a ? increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Dagi Shahar Ben-Noon also recently made the following trade(s):

• On Friday, October 9th, Dagi Ben-Noon acquired 18,181 shares of Inspira Technologies OXY B.H.N. stock. The stock was purchased at an average cost of $1.67 per share, with a total value of $30,362.27.
• On Monday, September 28th, Dagi Ben-Noon acquired 168,894 shares of Inspira Technologies OXY B.H.N. stock. The shares were purchased at an average price of $0.71 per share, for a total transaction of $119,914.74.

Inspira Technologies OXY B.H.N. Trading Up 1.6%

Shares of NASDAQ QTEX traded up $0.03 during trading on Tuesday, reaching $1.60. 6,279,581 shares of the stock were exchanged, compared to its average volume of 12,422,833. The business’s 50-day moving average price is $0.97. Inspira Technologies OXY B.H.N. Ltd has a twelve month low of $0.28 and a twelve month high of $3.85. The company has a current ratio of 2.00, a quick ratio of 1.62 and a debt-to-equity ratio of 0.12.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last released its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) earnings per share for the quarter. The company had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has approved a share repurchase program on Monday, June 22nd that permits the company to buy back 2,000,000,000,000 outstanding shares. This repurchase authorization permits the company to repurchase up to 5.6% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s leadership believes its shares are undervalued.

Analyst Ratings Changes

QTEX has been the subject of several recent analyst reports. Weiss Ratings downgraded Inspira Technologies OXY B.H.N. from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday. Wall Street Zen downgraded Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a report on Saturday, August 8th. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock has an average rating of “Sell”.

About Inspira Technologies OXY B.H.N.

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.